GALT: GALECTIN THERAPEUTICS INC insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-08-04 | 13D amendment | Richard E. Uihlein | 49.30% | SEC |
Institutional ownership (Q2 2026)
98 institutions reported holding $70.84M of GALECTIN THERAPEUTICS INC on Form 13F (99 the quarter before). 19 opened a new position and 20 sold out. Shares held by institutions: +13%.
| Largest holders | Shares | Value |
|---|---|---|
| BlackRock, Inc. | 2,988,353 | $13.87M |
| VANGUARD CAPITAL MANAGEMENT LLC | 2,168,065 | $10.06M |
| GEODE CAPITAL MANAGEMENT, LLC | 1,308,394 | $6.07M |
| OSAIC HOLDINGS, INC. | 1,203,725 | $5.59M |
| MARSHALL WACE, LLP | 831,010 | $3.86M |
| Wealthspire Advisors, LLC | 721,788 | $3.35M |
| STATE STREET CORP | 567,779 | $2.63M |
| COMMONWEALTH EQUITY SERVICES, LLC | 407,113 | $1.89M |
| NORTHERN TRUST CORP | 386,545 | $1.79M |
| VANGUARD FIDUCIARY TRUST CO | 366,476 | $1.70M |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.